Skip to content
GLP-1 Facelift

Facial changes after GLP-1 weight loss, and the surgery that addresses them

Sources, editorial approach and privacy

GLP-1 Facelift covers facial surgery after substantial weight loss, including facelift, neck lift, fat grafting and preparation for surgery in Korea.

Written by the GLP-1 Facelift editorial team from the sources listed on each page. Last updated: .

How are medical statements sourced?

Research references link to PubMed records. Study type and population are identified where they affect the meaning of a result. Findings from general facial surgery, massive-weight-loss cohorts and GLP-1 users are kept distinct. Professional guidance is linked with the date it was checked.

The citation records are checked against PubMed metadata and screened for retraction notices. Small observational studies and expert guidance are described as such. A reported average is not presented as an individual outcome, and a proposed biological mechanism is not treated as a demonstrated clinical effect.

What is the scope of the information?

The focus is surgical assessment and the questions needed to understand a proposed operation. Prescription selection, dose changes and personal medication schedules belong to the treating clinical team. Perioperative recommendations are attributed to their source and kept separate from individual instructions.[1]

Privacy

There are no forms on this site, and it does not ask visitors to submit personal or medical information. Page views and clicks on outbound links are measured with Google Analytics, which stores cookies in the browser; browser settings can refuse or remove them. External websites have their own privacy terms.

Checking a possible error

Use the numbered reference beside a claim to compare its wording with the source. Check the study population, measurement and publication date, then identify the sentence and source detail that appear inconsistent. A newer recommendation should also be checked against the document it replaces.

When contacting the Seoul facial surgery consultation service, check the recipient’s privacy policy before sharing clinical records.

References

(1)

Bibliographic records retrieved from PubMed (U.S. National Library of Medicine).

  1. Kindel TL, Wang AY, Wadhwa A, et al. Multi-society clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period. Surg Endosc. 2025;39(1):180-183.